A 'natural' weight loss product containing sibutramine.
نویسندگان
چکیده
For consumers who want to lose weight, using a product claiming to make that weight loss easier may be an attractive option. Herbal products are often perceived as safe because they are ‘natural’. However, these products are not free of risks. Herbal products themselves can be a cause of adverse drug reactions but these products can also be adulterated with active pharmacological ingredients. A recent Dutch study determined whether herbal food supplements for weight loss on the Dutch market contained active pharmacological ingredients with weight loss properties. This study found that in 50 samples collected from August 2004 to May 2013, in 24 samples sibutramine, desmethylsibutramine (DMS), didesmethylsibutramine (DDMS), rimonabant, sildenafil, and/or the laxative phenolphthalein were identified. Some samples contained multiple active pharmacological ingredients. The presence of these ingredients was not stated on the label. In addition, several other studies have identified sibutramine and other active pharmacological ingredient in supposedly ‘natural’ products. The Netherlands Pharmacovigilance Centre Lareb, located in ’s Hertogenbosch in the Netherlands, collects and analyzes reports of adverse drug reactions (ADRs). By maintaining the reporting system for ADRs, Lareb monitors the safety of medicines and vaccines in the Netherlands. In addition to monitoring the safety of registered drugs and vaccines, healthcare professionals and the general public can also report non-registered herbal products and food supplements including vitamins. In the Netherlands, herbal products can obtain marketing authorization through the Dutch Medicines Evaluation Board (MEB) in the case that the same efficacy and safety data are available as for ‘regular’ drugs. A manufacturer can also apply for a marketing authorization as a ‘traditional herbal drug’ through the MEB, meaning that the efficacy of these products is assessed not by clinical testing but on the basis of a long history of use and experience. If an herbal product is not registered through the MEB, it falls under the Dutch Commodities Act. Information on the reported ADRs of these products under the Dutch Commodities Act is shared with the Netherlands Food and Consumer Product Safety Authority (NVWA). At present, the database of Lareb contains 39 reports about unregistered slimming products, of which 9 were suspected of being adulterated with an illegal active pharmacological ingredient. In an additional 7 cases, high dosages of caffeine were added to weight loss products containing cactus, Aurantii pericarpium (bitter orange), Yerbamate (leaves), Guarana (Seeds), and Kola nut (seeds). For products where such a suspicion arises, Lareb requests the reporter (either a healthcare professional or consumer) to send a
منابع مشابه
A survey on clinical effectiveness of orlistat compared to sibutramine, lorcaserin, metformin and placebo on weight loss in obese people: a network meta-analysis
Background: Trying to find a drug with more clinical efficacy in treating obesity is one of the priorities. The aim of this study was to evaluate the efficacy of orlistat, sibutramine, lorcaserin and metformin on weight loss in obese people. Methods: The databases of PubMed, Scopus, Google Scholar and Cochran Library were searched up to November 2016. In present study search strategy was perfo...
متن کاملCardiac arrest caused by sibutramine obtained over the Internet: a case of a young woman without pre‐existing cardiovascular disease successfully resuscitated using extracorporeal membrane oxygenation
Case Sibutramine is a weight loss agent that was withdrawn from the market in the USA and European Union because it increases adverse events in patients with cardiovascular diseases. However, non-prescription weight loss pills containing sibutramine can be still easily purchased over the Internet. A 21-year-old woman without history of cardiovascular diseases developed cardiac arrest. She was a...
متن کاملA common variant in the adiponectin gene on weight loss and body composition under sibutramine therapy in obesity
In this study, we aimed to explore whether a common single nucleotide polymorphism (SNP), rs266729 (-11,377C > G), in the adiponectin C1Q and collagen domain containing (ADIPOQ) gene could influence weight reduction and fat change under sibutramine therapy in an obese population. There were 131 obese Taiwanese patients, including 44 in the placebo group and 87 in the sibutramine (10 mg daily) g...
متن کاملSibutramine plus meal replacement therapy for body weight loss and maintenance in obese patients.
OBJECTIVE Our objective was to assess the efficacy and safety of sibutramine with a low-calorie diet (LCD) and commercial meal-replacement product in achieving weight loss and weight-loss maintenance in obese patients. RESEARCH METHODS AND PROCEDURES Eight U.S. centers recruited 148 obese patients for a 3-month comprehensive weight-loss therapy (Phase I) comprising daily sibutramine 10 mg + L...
متن کاملSibutramine. A review of its contribution to the management of obesity.
Sibutramine is an orally administered centrally acting weight management agent apparently devoid of amphetamine-like abuse potential. Its primary (M2; BTS 54,505) and secondary (M1; BTS 54,354) amine metabolites are pharmacologically active and are thought to induce the natural processes leading to enhancement of satiety and thermogenesis by inhibiting serotonin (5-hydroxytryptamine, 5-HT) and ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Drug testing and analysis
دوره 8 3-4 شماره
صفحات -
تاریخ انتشار 2016